English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
StatusNot yet recruiting
Sponsors
Nantes University Hospital

Keywords

Abstract

Reversible Cerebral Vasoconstriction Syndrome (RCVS) is a syndrome described at the end of the 20th century. Generally, it has a benign course. It is revealed by acute headaches, in different circumstances such as sexual activity, physical exertion or emotional disturbances. But, in few cases, it might be complicated by seizure, stroke and subarachnoid haemorrhage. The diagnosis is confirmed on radiological examination, which shows diffuse cerebral vasoconstriction of brain vessel. It calls reversible because at three month, vasoconstriction disappears. Most cases occur during post partum or after serotoninergic/adrenergic drug use. The pathophysiology is unknown but a transient disturbance in the control of cerebrovascular tone by sympathic hyperactivity and/or endothelial dysfunction are suspected. The assessment of endothelial dysfunction in brain is possible with transcranial doppler. Chen et al. showed an impairment of vasodilatation post apnea induced called BHI on RCVS subjects compared with healthy control. BHI is a reflect of endothelial function in brain. Currently, investigators do not know if endothelial dysfunction occurred only in brain or if it may occur in systemic vessel. Some case reports talk about systemic complication such as kidney infarct or hepatic arterial vasospasm so a systemic vascular dysfunction may be suspected. In this study, researchers will study systemic endothelial function by measure of the pulse wave velocity during RCVS and after its recovering at 3 months, and compare it at healthy controls.

Description

The investigators lead a case control study to find a systemic endothelial dysfunction by the using of Complior device. Complior is a mechanographer who calculates pulse wave velocity (PWV). Pulse wave velocity is a reflect of arterial stiffness and it's correlate with endothelial dysfunction. For BHI, a Philips echograph is used before and after 30 second of breath holding.

Study protocol is :

For Patient :

- Day 0 : in hospital : anamnesis, medical history, physic examination, EKG, blood sample analysis, BHI, PWV analysis

- Month 1 : in medical visit : medical evolution, physic examination, EKG, blood sample analysis, BHI, PWV analysis

- Month 3 : in medical visit : medical evolution, physic examination, EKG, blood sample analysis, BHI, PWV analysis, cerebral angioCT Scan

For control :

- Day 0 : in hospital : medical history, physic examination, EKG, BHI, PWV analysis

Dates

Last Verified: 06/30/2020
First Submitted: 07/02/2020
Estimated Enrollment Submitted: 07/02/2020
First Posted: 07/08/2020
Last Update Submitted: 07/23/2020
Last Update Posted: 07/27/2020
Actual Study Start Date: 09/30/2020
Estimated Primary Completion Date: 12/31/2022
Estimated Study Completion Date: 12/31/2022

Condition or disease

Reversible Cerebral Vasoconstriction Syndrome

Phase

-

Arm Groups

ArmIntervention/treatment
Patient
Diagnosis of probable SVCR evoked, faced with a single or repeated episode of unusual thunderclap or rapidly progressive headache, and demonstration of diffuse vasospasms via sectional imaging (angiography, angio-MRI or cerebral arteriography) or an increase in transcranial doppler speeds
Subject control
Subject without SVCR (current and history)

Eligibility Criteria

Ages Eligible for Study 18 Years To 18 Years
Sexes Eligible for StudyAll
Sampling methodNon-Probability Sample
Accepts Healthy VolunteersYes
Criteria

Inclusion Criteria for patients :

- Aged from 18 to 80 years old

- RVCS diagnosis evoked on clinic and radiologic finding

- Last headache was 15 days ago

- Oral consent

- Register in French social security

Inclusion criteria for control :

- Aged from 18 to 80 years old

- Hypothesis of RCVS in clinical presentation and on cerebral imaging

- Last headache less than 3 days old

- Oral consent

- Register in French social security

- Person under guardianship, curatorship or safeguarding of justice

Exclusion Criteria:

Non inclusion criteria for patient :

- Pregnant women

- Tobacco, coffee, alcohol, drugs or vasoactive recreational substances use within 2 hours prior to the examination.

- Person under guardianship, curatorship or safeguarding of justice

- Non sinusal rhythm on EKG

- Impossible of Breath holding for 30 secondes

Exclusion criteria for patient :

- No reversibility at 3 months

Non inclusion criteria for control :

- Pregnant women

- Tobacco, coffee, alcohol, drugs or vasoactive recreational substances use within 2 hours prior to the examination.

- Non sinusal rhythm on EKG

- Impossible of Breath holding for 30 secondes

Outcome

Primary Outcome Measures

1. Compare systemic endothelial function between patient and healthy subject [24 hours]

By using Complior, researchers assess systemic endothelial function at inclusion on patient and healthy volunteer person by pulse wave velocity (cm.s-1)

Secondary Outcome Measures

1. BHI (Breath Holding Index) [at day 0, month 1, month 3]

BHI measure on middle cerebral arteries by transcranial ultrasound

2. Pulse wave velocity (PWV) [at day 0, month 1, month 3]

Pulse wave velocity mesaure from carotid to femoral artery

3. Relationship between cerebral and systemic endothelial function [at day 0, month 1, month 3]

Comparison of BHI and VOP evolution

4. Renal failure [Day 0]

Diminution of creatinin clearance<100 ml/min/1.73m2

5. Occurence of stroke or cerebral oedema [at day 0, month 1, month 3]

Occurrence of ischemic stroke, cerebral haemorrhage, cerebral oedema

6. Comparison of PWV between patients with or without arterial hypertension [at day 0, month 1, month 3]

Comparison between middle PWV (cm/s) of patients with arterial hypertension and patients without arterial hypertension

7. Comparison of BHI between patients with or without arterial hypertension [at day 0, month 1, month 3]

Comparison between middle BHI of patients with arterial hypertension and patients without arterial hypertension

8. Comparison between PWV (cm/s) [at 3 months]

Comparison between PWV (cm/s) between patients and control group

9. Comparison between BHI (cm/s) [at 3 months]

Comparison between BHI (cm/s) between patients and control group

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge